
BASF broadens biotech business by Isobionics acquisition
The acquisition of Isobionics BV (Geleen, The Netherlands) gives the the German world chemistry leader a foothold in the growing US$20.75bn market...

Tecentriq-Avastin combo hits endpoint in liver cancer
Data from 501 treatment-native HCC patients enrolled in the open label IMbrave150 Phase III study demonstrated a incremental improvement...

Inotrem SA raises €39m to provide POC for nangibotide
The Series B round was led by Morningside Ventures with Invus contributing as new investors. Existing investors participating were Andera Partners,...

Researchers identify viral inflammation switch
Their findings in mice models that were infected with the Influenza A virus may have also impact on further virally induced inflammations,researchers...

Cell transdifferentiation specialist Mogrify Ltd raises US$16m
The company has developed a unique scalable technology for direct cellular transdifferentiation, based on the FANTOM5 dataset of human regulatory...

Gut bacterial enzyme keeps inflammation away
In studies in human cells, Victor Duarte and colleagues from University of Grenoble, found broad-spectrum antimicrobial activity of a compound...

Research team improves safety of LGMD2A gene therapy
Limb-girdle muscular dystrophy type 2A (LGMD2A or LGMDR1) is a neuromuscular disorder hat causes progressive muscle weakness and has no cure. The...